161 related articles for article (PubMed ID: 10494783)
1. D-glucose increases the synthesis of tissue-type plasminogen activator (t-PA) in human peritoneal mesothelial cells.
Sitter T; Mandl-Weber S; Wörnle M; Haslinger B; Goedde M; Kooistra T
Thromb Haemost; 1999 Sep; 82(3):1171-6. PubMed ID: 10494783
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin increases fibrinolytic activity in human peritoneal mesothelial cells independent of cholesterol lowering.
Haslinger B; Goedde MF; Toet KH; Kooistra T
Kidney Int; 2002 Nov; 62(5):1611-9. PubMed ID: 12371961
[TBL] [Abstract][Full Text] [Related]
3. Glucose-based PD solution, but not icodextrin-based PD solution, induces plasminogen activator inhibitor-1 and tissue-type plasminogen activator in human peritoneal mesothelial cells via ERK1/2.
Katsutani M; Ito T; Masaki T; Kohno N; Yorioka N
Ther Apher Dial; 2007 Apr; 11(2):94-100. PubMed ID: 17381529
[TBL] [Abstract][Full Text] [Related]
4. Thrombin upregulates production of plasminogen activator inhibitor type 1 in human peritoneal mesothelial cells.
Mandl-Weber S; Haslinger B; Sitter T
Perit Dial Int; 1999; 19(4):319-24. PubMed ID: 10507812
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-alpha-activated human peritoneal mesothelial cells.
Haslinger B; Kleemann R; Toet KH; Kooistra T
Kidney Int; 2003 Jun; 63(6):2065-74. PubMed ID: 12753293
[TBL] [Abstract][Full Text] [Related]
6. Modulation of procoagulant and fibrinolytic system components of mesothelial cells by inflammatory mediators.
Sitter T; Toet K; Fricke H; Schiffl H; Held E; Kooistra T
Am J Physiol; 1996 Nov; 271(5 Pt 2):R1256-63. PubMed ID: 8945961
[TBL] [Abstract][Full Text] [Related]
7. Effect of high glucose concentration on the synthesis of monocyte chemoattractant protein-1 in human peritoneal mesothelial cells: involvement of protein kinase C.
Haslinger B; Mandl-Weber S; Sellmayer A; Lederer SR; Sitter T
Nephron; 2001 Apr; 87(4):346-51. PubMed ID: 11287779
[TBL] [Abstract][Full Text] [Related]
8. High glucose increases prostaglandin E2 synthesis in human peritoneal mesothelial cells: role of hyperosmolarity.
Sitter T; Haslinger B; Mandl S; Fricke H; Held E; Sellmayer A
J Am Soc Nephrol; 1998 Nov; 9(11):2005-12. PubMed ID: 9808086
[TBL] [Abstract][Full Text] [Related]
9. Heat-killed microorganisms induce PAI-1 expression in human peritoneal mesothelial cells: role of interleukin-1alpha.
Mandl-Weber S; Haslinger B; Lederer SR; Sitter T
Am J Kidney Dis; 2001 Apr; 37(4):815-9. PubMed ID: 11273882
[TBL] [Abstract][Full Text] [Related]
10. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.
Hagège J; Delarue F; Peraldi MN; Sraer JD; Rondeau E
Lab Invest; 1994 Dec; 71(6):828-37. PubMed ID: 7807964
[TBL] [Abstract][Full Text] [Related]
11. Effect of Tisseel on expression of tissue plasminogen activator and plasminogen activator inhibitor-1.
Diamond MP; Kruger M; Saed GM
Fertil Steril; 2004 Jun; 81(6):1657-64. PubMed ID: 15193491
[TBL] [Abstract][Full Text] [Related]
12. Functional properties of mesothelial cells after prolonged exposure to dialysate effluent.
Breborowicz A; Karon J; Korybalska K; Martis L; Oreopoulos DG
Adv Perit Dial; 1995; 11():15-8. PubMed ID: 8534691
[TBL] [Abstract][Full Text] [Related]
13. Time to reconsider saline as the ideal rinsing solution during abdominal surgery.
Połubinska A; Winckiewicz M; Staniszewski R; Breborowicz A; Oreopoulos DG
Am J Surg; 2006 Sep; 192(3):281-5. PubMed ID: 16920418
[TBL] [Abstract][Full Text] [Related]
14. Biphasic regulation of plasminogen activator/inhibitor by LDL in mesangial cells.
Song CY; Kim BC; Hong HK; Kim BK; Kim YS; Lee HS
Am J Physiol Renal Physiol; 2002 Sep; 283(3):F423-30. PubMed ID: 12167592
[TBL] [Abstract][Full Text] [Related]
15. Prednisolone inhibits hyperosmolarity-induced expression of MCP-1 via NF-kappaB in peritoneal mesothelial cells.
Matsuo H; Tamura M; Kabashima N; Serino R; Tokunaga M; Shibata T; Matsumoto M; Aijima M; Oikawa S; Anai H; Nakashima Y
Kidney Int; 2006 Feb; 69(4):736-46. PubMed ID: 16518329
[TBL] [Abstract][Full Text] [Related]
16. In vitro simulation of the effect of peritoneal dialysis solution on mesothelial cells.
Breborowicz A; Rodela H; Karoń J; Martis L; Oreopoulos DG
Am J Kidney Dis; 1997 Mar; 29(3):404-9. PubMed ID: 9041217
[TBL] [Abstract][Full Text] [Related]
17. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
Sitter T; Toet K; Quax P; Kooistra T
Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
[TBL] [Abstract][Full Text] [Related]
18. Effects of glucose and plasminogen activator inhibitor-1 on collagen metabolism in the peritoneum.
Higuchi C; Tanihata Y; Nishimura H; Naito T; Sanaka T
Ther Apher Dial; 2005 Apr; 9(2):173-81. PubMed ID: 15828931
[TBL] [Abstract][Full Text] [Related]
19. Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity.
Aarons CB; Cohen PA; Gower A; Reed KL; Leeman SE; Stucchi AF; Becker JM
Ann Surg; 2007 Feb; 245(2):176-84. PubMed ID: 17245169
[TBL] [Abstract][Full Text] [Related]
20. Chronic exposure of human mesangial cells to high glucose environments activates the p38 MAPK pathway.
Wilmer WA; Dixon CL; Hebert C
Kidney Int; 2001 Sep; 60(3):858-71. PubMed ID: 11532081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
